Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancerLang Li(Zhejiang Chinese Medical University), Ying Zhu(Beijing Biocytogen (China))Journal Of Big DataSeptember 28, 202310.1186/s40537-023-00826-0Cited by 2SaveCiteExport RISWatch citationsRelated PapersNovel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.|Journal of Clinical Oncology|2023|1